Uncategorized
MGD patients with Sjögren’s biomarkers benefit from thermal pulsation
Thermal pulsation treatment for meibomian gland dysfunction patients who were positive for novel biomarkers of Sjögren’s syndrome showed improvement in the signs and symptoms of dry eye, according to researchers in Clinical Ophthalmology. A total of 102 eyes from 59 patients with dry eye and meibomian gland dysfunction (MGD) were tested for novel biomarkers for Sjögren’s and underwent a single 12-minute LipiFlow thermal pulsation (TearScience) procedure.